NASONEX

This brand name is authorized in Austria, Brazil, Canada, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, United States, South Africa

Active ingredients

The drug NASONEX contains one active pharmaceutical ingredient (API):

1 Mometasone UNII MTW0WEG809 - MOMETASONE FUROATE MONOHYDRATE

Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade. Read about Mometasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NASONEX Nasal Spray, Suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
NASONEX Nasal spray	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AD09	Mometasone	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 527315120017617, 527315120017717
Country: CA	Health Products and Food Branch	Identifier(s): 02238465
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00055509, 02193150, 05049548, 05120832, 10663256
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 22.376-1-08-05
Country: EE	Ravimiamet	Identifier(s): 1028966, 1726501, 1726512, 1726523, 1820135, 1820168, 1823554, 1823587
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61905, BE190854, BE190854IP
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 474551, 474643
Country: FR	Base de données publique des médicaments	Identifier(s): 63566855
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139359, 143237, 26794
Country: HK	Department of Health Drug Office	Identifier(s): 43556
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-032470068
Country: IE	Health Products Regulatory Authority	Identifier(s): 31587, 35235, 67120, 67145
Country: JP	医薬品医療機器総合機構	Identifier(s): 1329710Q1027, 1329710Q2023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003843, 1068854, 1077869, 1077870, 1079727, 1081256, 1082883, 1085547, 1085569, 1089255, 1089256
Country: MT	Medicines Authority	Identifier(s): MA031/01901, PI770/10401A, PI908/12702A
Country: NL	Z-Index G-Standaard	Identifier(s): 14269961
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 52434
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7958
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100080562, 100157980, 100346267, 100351831, 100355964, 100363923, 100370544, 100384078, 100386634, 100460850, 100467170
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68334001, W68334002, W68334003, W68334004
Country: SG	Health Sciences Authority	Identifier(s): 10763P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6523111
Country: US	FDA, National Drug Code	Identifier(s): 0085-1288
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/21.5.1/0157, 36/21.5.1/0414